Stay updated on Gebasaxturev Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.

Latest updates to the Gebasaxturev Combo in Melanoma Clinical Trial page
- Check5 days agoChange DetectedA new study record revision, v3.5.3, was added to the history, and the previous revision v3.5.2 was removed from the current version list.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.2 was added as the latest version, replacing v3.5.0 in the history.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedRevision: v3.5.0 was added to the Record History page and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision history updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded Revision: v3.4.2 to the history; removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check91 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center’s status was added, along with the new page revision label Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Gebasaxturev Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.